Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS-NSQIP follow up analysis.

Judge SJ, Lata-Arias K, Yanagisawa M, Darrow MA, Monjazeb AM, Kirane AR, Bold RJ, Canter RJ, Canter DJ.

J Surg Oncol. 2019 Sep;120(4):753-760. doi: 10.1002/jso.25649. Epub 2019 Jul 29.

PMID:
31355444
2.

Role of Radiation Therapy in Adult Extraskeletal Ewing's Sarcoma Patients Treated with Chemotherapy and Surgery.

Saiz AM Jr, Gingrich AA, Canter RJ, Kirane AR, Monjazeb AM, Randall RL, Thorpe SW.

Sarcoma. 2019 Apr 24;2019:5413527. doi: 10.1155/2019/5413527. eCollection 2019.

3.

Extremity soft tissue sarcoma in the elderly: Are we overtreating or undertreating this potentially vulnerable patient population?

Gingrich AA, Bateni SB, Monjazeb AM, Thorpe SW, Kirane AR, Bold RJ, Canter RJ.

J Surg Oncol. 2019 Jun;119(8):1087-1098. doi: 10.1002/jso.25470. Epub 2019 Apr 12.

PMID:
30977916
4.

Clinical Outcomes and Costs Following Unplanned Excisions of Soft Tissue Sarcomas in the Elderly.

Bateni SB, Gingrich AA, Jeon SY, Hoch JS, Thorpe SW, Kirane AR, Bold RJ, Canter RJ.

J Surg Res. 2019 Jul;239:125-135. doi: 10.1016/j.jss.2019.01.055. Epub 2019 Feb 27.

PMID:
30825757
5.

Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study.

Cassidy MR, Lefkowitz RA, Long N, Qin LX, Kirane A, Sbaity E, Hameed M, Coit DG, Brennan MF, Singer S, Crago AM.

Ann Surg. 2018 Nov 9. doi: 10.1097/SLA.0000000000003073. [Epub ahead of print]

PMID:
30418203
6.

Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Preclinical Models of Pancreatic Cancer.

Zhang Y, Kirane A, Huang H, Sorrelle NB, Burrows FJ, Dellinger MT, Brekken RA.

Mol Cancer Res. 2019 Feb;17(2):348-355. doi: 10.1158/1541-7786.MCR-18-0427. Epub 2018 Oct 17.

PMID:
30333153
7.

Tumor Symbiosis: Gastrointestinal Stromal Tumor as a Host for Primary Peritoneal Mesothelioma.

de la Torre J, Banerjee S, Baumgartner J, Lin GY, Burgoyne AM, Kirane A, Sicklick J.

J Gastrointest Surg. 2019 Apr;23(4):879-881. doi: 10.1007/s11605-018-3918-3. Epub 2018 Aug 21. No abstract available.

PMID:
30132292
8.

Serum C-reactive Protein and Neutrophil/Lymphocyte Ratio After Neoadjuvant Radiotherapy in Soft Tissue Sarcoma.

Yanagisawa M, Gingrich AA, Judge S, Li CS, Wang N, Thorpe SW, Kirane AR, Bold RJ, Monjazeb AM, Canter RJ.

Anticancer Res. 2018 Mar;38(3):1491-1497.

9.

T Cells Dominate the Local Immune Response Induced by Intralesional IL-2 in Combination with Imiquimod and Retinoid for In-Transit Metastatic Melanoma.

Ogawa H, Luxardi G, Kirane A, Kulkarni R, Monjazeb AM, Cheng MY, Ma C, Maverakis E.

J Invest Dermatol. 2018 Jun;138(6):1442-1445. doi: 10.1016/j.jid.2017.12.027. Epub 2017 Dec 29. No abstract available.

10.

Size and Location are the Most Important Risk Factors for Malignant Behavior in Resected Solitary Fibrous Tumors.

Gholami S, Cassidy MR, Kirane A, Kuk D, Zanchelli B, Antonescu CR, Singer S, Brennan M.

Ann Surg Oncol. 2017 Dec;24(13):3865-3871. doi: 10.1245/s10434-017-6092-z. Epub 2017 Oct 16.

PMID:
29039030
11.

Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis.

Gingrich AA, Bateni SB, Monjazeb AM, Darrow MA, Thorpe SW, Kirane AR, Bold RJ, Canter RJ.

Ann Surg Oncol. 2017 Oct;24(11):3252-3263. doi: 10.1245/s10434-017-6019-8. Epub 2017 Jul 24.

12.

The modified frailty index to predict morbidity and mortality for retroperitoneal sarcoma resections.

Park JS, Bateni SB, Bold RJ, Kirane AR, Canter DJ, Canter RJ.

J Surg Res. 2017 Sep;217:191-197. doi: 10.1016/j.jss.2017.05.025. Epub 2017 May 11.

13.

The importance of surgical margins in retroperitoneal sarcoma.

Kirane A, Crago AM.

J Surg Oncol. 2016 Mar;113(3):270-6. doi: 10.1002/jso.24135. Epub 2015 Dec 28. Review.

PMID:
26707028
14.

"Informed" Consent: An Audit of Informed Consent of Cesarean Section Evaluating Patient Education and Awareness.

Kirane AG, Gaikwad NB, Bhingare PE, Mule VD.

J Obstet Gynaecol India. 2015 Dec;65(6):382-5. doi: 10.1007/s13224-014-0651-z. Epub 2015 Feb 15.

15.

Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.

Kirane A, Ludwig KF, Sorrelle N, Haaland G, Sandal T, Ranaweera R, Toombs JE, Wang M, Dineen SP, Micklem D, Dellinger MT, Lorens JB, Brekken RA.

Cancer Res. 2015 Sep 15;75(18):3699-705. doi: 10.1158/0008-5472.CAN-14-2887-T. Epub 2015 Jul 23.

16.

Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.

Kirane A, Toombs JE, Ostapoff K, Carbon JG, Zaknoen S, Braunfeld J, Schwarz RE, Burrows FJ, Brekken RA.

Clin Cancer Res. 2012 Sep 15;18(18):5031-42. doi: 10.1158/1078-0432.CCR-12-0453. Epub 2012 Jul 24.

17.

Epithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib.

Kirane A, Toombs JE, Larsen JE, Ostapoff KT, Meshaw KR, Zaknoen S, Brekken RA, Burrows FJ.

Carcinogenesis. 2012 Sep;33(9):1639-46. doi: 10.1093/carcin/bgs195. Epub 2012 Jun 7.

18.

Intraduodenal sarcoma recurrence of retroperitoneal origin: an unusual cause for a duodenal obstruction.

Bao JJ, Mansour JC, Timmerman RD, Kirane A, Ewing GE, Schwarz RE.

World J Surg Oncol. 2012 Apr 20;10:59. doi: 10.1186/1477-7819-10-59.

19.

Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer.

Awasthi N, Kirane A, Schwarz MA, Toombs JE, Brekken RA, Schwarz RE.

BMC Cancer. 2011 Jan 12;11:15. doi: 10.1186/1471-2407-11-15.

Supplemental Content

Loading ...
Support Center